Accelerating human antibody discovery and R&D sourcing
Key takeaways from this case study:
Rapid antibody candidate identification: Discover how Infinimmune screens millions of B cells across 350+ targets to identify drug candidates in just 8 weeks.
Access to high-quality clinical data: Learn the importance of sourcing specific human donor cohorts with rich pathology reports and response data.
Overcoming sourcing delays: See how traditional academic sourcing routes can take up to 11 months for targeted donor samples.
97% faster sample turnaround: Read how Specie Bio delivered matched samples and clinical data in just 2.5 weeks instead of months.
Accelerate your R&D pipeline: Gain key insights on streamlining sample procurement and contracting to eliminate R&D bottlenecks.